Ozempic & GLP-1 drugs - Why 90% Still Fail | Prevention is Cure Ep# 45

In this episode of Prevention Is Cure, Prof Grant Schofield and Sam Schofield dive deep into the most explosive topic in metabolic health right now - have we actually cracked weight loss and aging? From the latest GLP-1 triple agonists showing 30% body weight loss, to gene therapies that can reverse the age of individual cells, the science is moving faster than most people realise.But here's the uncomfortable truth: 9 out of 10 people regain the weight when they stop. The "Ozempic personality" is real. And the first human trial of Yamanaka factor therapy just began.We cover:→ The 4 weight loss options (and which actually works long-term)→ The newest GLP-1 drugs you've never heard of — and can't pronounce→ What "food noise" is and why killing it might cost you more than hunger→ Longevity escape velocity — the first person to live to 1,000 may already be born→ Yamanaka factors and the science of reversing cellular age→ Why Grant believes prescribing these drugs without behaviour change is unethical🎙️ Prevention Is Cure with Prof Grant Schofield & Guest Host Sam SchofieldSubscribe for conversations on metabolic health, longevity, and the science of living well. #weightloss #GLP1 #Ozempic #longevity #metabolichealth #preventioniscure